ATEC Announces Proposed Public Offering of Common Stock
October 13 2020 - 4:03PM
Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of
innovative spine surgery solutions dedicated to revolutionizing the
approach to spine surgery, today announced that it has commenced an
underwritten public offering of $85 million of shares of its common
stock. In connection with the offering, ATEC intends to grant the
underwriters a 30-day option to purchase up to an additional 15% of
the number of shares of common stock sold in the offering. All of
the shares in the offering are to be sold by ATEC. There can be no
assurance as to whether or when the offering may be completed, or
as to the actual size or terms of the offering.
Morgan Stanley and Cowen are acting as
joint book-running managers in the offering. Canaccord
Genuity, LLC is acting as lead manager in the offering with Lake
Street Capital Markets, LLC and Northland Capital Markets acting as
co-managers.
The shares of common stock are being offered
pursuant to a shelf registration statement on Form S-3 (File
No. 333-241677) previously filed with and declared effective
by the Securities and Exchange Commission. The offering will
be made only by means of a written prospectus and prospectus
supplement. A preliminary prospectus supplement and accompanying
prospectus relating to the offering will be filed with the SEC and
will be available on the SEC’s website at www.sec.gov.
When available, copies of the preliminary
prospectus supplement and accompanying prospectus may also be
obtained from Morgan Stanley, Attention: Prospectus
Department, 180 Varick Street, 2nd Floor, New York, New York 10014,
or by e-mail at prospectus@morganstanley.com or Cowen, c/o
Broadridge Financial Solutions, Attn: Prospectus Department, 1155
Long Island Avenue, Edgewood, NY 11717, by telephone at (833)
297-2926 or by email at PostSaleManualRequests@broadridge.com. This
press release shall not constitute an offer to sell nor the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. The offering may only be made by means of a
prospectus supplement and related base prospectus.
About ATEC
Alphatec Holdings, Inc. (ATEC), through its
wholly-owned subsidiaries, Alphatec Spine,
Inc. and SafeOp Surgical, Inc., is a medical device
company dedicated to revolutionizing the approach to spine surgery
through clinical distinction. ATEC’s Organic Innovation Machine is
focused on developing new approaches that integrate seamlessly with
the SafeOp Neural InformatiX System to safely and reproducibly
treat spine’s various pathologies and achieve the goals of spine
surgery. Alphatec’s vision is to become the Standard Bearer in
Spine.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 that involve risks and uncertainty. Such
statements are based on management's current expectations and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. ATEC cautions investors that there can
be no assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors. The
words “believe,” “will,” “should,” “expect,” “intend,” “estimate,”
“look forward” and “anticipate,” variations of such words and
similar expressions identify forward-looking statements, but their
absence does not mean that a statement is not a forward-looking
statement. A further list and description of these and other
factors, risks and uncertainties can be found in ATEC’s most recent
annual report, any subsequent quarterly and current reports, and
certain other filings, filed with the Securities and Exchange
Commission. ATEC disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events, or otherwise, unless required by
law.
Company Contact:Jeff BlackChief
Financial OfficerInvestorRelations@atecspine.com
Investor/Media Contact:Tina
JacobsenInvestor Relations(760)
494-6790InvestorRelations@atecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024